应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06622 兆科眼科-B
未开盘 04-15 15:58:55
3.050
+0.000
0.00%
最高
3.100
最低
3.020
成交量
30.05万
今开
3.090
昨收
3.050
日振幅
2.62%
总市值
16.74亿
流通市值
16.74亿
总股本
5.49亿
成交额
92.22万
换手率
0.05%
流通股本
5.49亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
兆科眼科-B更新3月股份变动月报表,股本维持稳定
公告速递 · 04-01
兆科眼科-B更新3月股份变动月报表,股本维持稳定
李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%
智通财经 · 03-30
李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%
李氏大药厂(00950):茵若飒取得国家药监局批准
智通财经 · 03-25
李氏大药厂(00950):茵若飒取得国家药监局批准
兆科眼科-B 2025年收入回落,持续推进多款眼科创新药布局
公告速递 · 03-25
兆科眼科-B 2025年收入回落,持续推进多款眼科创新药布局
兆科眼科-B(06622)公布2025年业绩 税后亏损约2.09亿元 同比收窄12%
智通财经 · 03-25
兆科眼科-B(06622)公布2025年业绩 税后亏损约2.09亿元 同比收窄12%
兆科眼科-B(06622.HK)拟3月25日举行董事会会议批准全年业绩
中金财经 · 03-11
兆科眼科-B(06622.HK)拟3月25日举行董事会会议批准全年业绩
兆科眼科-B03月09日获主力加仓68.0万元
市场透视 · 03-09
兆科眼科-B03月09日获主力加仓68.0万元
李氏大药厂03月04日主力净流出47.4万元 散户资金买入
市场透视 · 03-04
李氏大药厂03月04日主力净流出47.4万元 散户资金买入
兆科眼科(06622)公布2月股份变动月报表,股本小幅增加
公告速递 · 03-03
兆科眼科(06622)公布2月股份变动月报表,股本小幅增加
李氏大药厂03月02日主力净流出63.4万元 散户资金买入
市场透视 · 03-02
李氏大药厂03月02日主力净流出63.4万元 散户资金买入
李氏大药厂02月27日主力净流入18.6万元 散户资金抛售
市场透视 · 02-27
李氏大药厂02月27日主力净流入18.6万元 散户资金抛售
李氏大药厂02月13日主力净流入23.7万元 散户资金抛售
市场透视 · 02-13
李氏大药厂02月13日主力净流入23.7万元 散户资金抛售
兆科眼科-B盘中异动 股价大涨5.11%
市场透视 · 02-06
兆科眼科-B盘中异动 股价大涨5.11%
李氏大药厂02月04日主力净流出18.0万元 散户资金买入
市场透视 · 02-04
李氏大药厂02月04日主力净流出18.0万元 散户资金买入
兆科眼科-B02月04日主力净流出25.5万元 散户资金买入
市场透视 · 02-04
兆科眼科-B02月04日主力净流出25.5万元 散户资金买入
兆科眼科-B盘中异动 股价大跌5.16%报3.490港元
市场透视 · 02-02
兆科眼科-B盘中异动 股价大跌5.16%报3.490港元
全球首个复方老花眼滴眼液获FDA批准上市,兆科眼科-B(6622.HK)抢占眼科创新赛道先机
格隆汇 · 01-30
全球首个复方老花眼滴眼液获FDA批准上市,兆科眼科-B(6622.HK)抢占眼科创新赛道先机
兆科眼科-B(06622):Tenpoint接获FDA在美国就BRIMOCHOL™ PF发出的批准
智通财经 · 01-29
兆科眼科-B(06622):Tenpoint接获FDA在美国就BRIMOCHOL™ PF发出的批准
港股兆科眼科-B(06622.HK)盘中涨超7%
每日经济新闻 · 01-29
港股兆科眼科-B(06622.HK)盘中涨超7%
港股异动 | 兆科眼科-B(06622)盘中涨超7% 公司扩大与AFT的合作至新加坡 与千寿达成越南合作协议
智通财经 · 01-29
港股异动 | 兆科眼科-B(06622)盘中涨超7% 公司扩大与AFT的合作至新加坡 与千寿达成越南合作协议
加载更多
公司概况
公司名称:
兆科眼科-B
所属市场:
SEHK
上市日期:
--
主营业务:
兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司的主要产品包括用于治疗近视的NVK002(阿托品)、用于治疗干眼症的环孢素A眼凝胶以及用于治疗wAMD的TAB014(贝伐单抗)。该公司产品主要用于干眼症(DED)、近视、老花眼、湿性老年黄斑部病变(wAMD)和糖尿病黄斑水肿(DME)、青光眼及角膜上皮细胞功能障碍(CED)等影响眼前节及眼后节的眼科疾病的治疗。该公司在中国国内及海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06622","market":"HK","secType":"STK","nameCN":"兆科眼科-B","latestPrice":3.05,"timestamp":1776239935337,"preClose":3.05,"halted":0,"volume":300500,"delay":0,"changeRate":0,"floatShares":549000000,"shares":549000000,"eps":-0.43905537676663214,"marketStatus":"未开盘","change":0,"latestTime":"04-15 15:58:55","open":3.09,"high":3.1,"low":3.02,"amount":922235,"amplitude":0.02623,"askPrice":3.05,"askSize":19000,"bidPrice":3.03,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.43905537676663214,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776303000000},"marketStatusCode":0,"adr":0,"listingDate":1619625600000,"exchange":"SEHK","adjPreClose":3.05,"openAndCloseTimeList":[[1776216600000,1776225600000],[1776229200000,1776240000000]],"volumeRatio":0.6359788358980768,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06622","defaultTab":"news","newsList":[{"id":"1146829215","title":"兆科眼科-B更新3月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1146829215","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146829215?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:45","pubTimestamp":1775033145,"startTime":"0","endTime":"0","summary":"兆科眼科有限公司于2026年4月1日发布2026年3月股份变动月报表,报告期截至3月31日。根据公告,公司的注册股本维持在400,000美元,报告期末已发行股份总数保持为548,749,012股,未发生新的股份发行或购回注销情况,整体股本结构未见变动。上述期权变动并未造成任何新增股份的发行,亦无库存股份减持或转让。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623318798","title":"李氏大药厂(00950)发布年度业绩 股东应占溢利9193.8万港元 同比减少1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623318798","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623318798?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:19","pubTimestamp":1774862354,"startTime":"0","endTime":"0","summary":"智通财经APP讯,李氏大药厂(00950)发布截至2025年12月31日止年度业绩,集团收益14.36亿港元,同比增长2.6%;股东应占溢利9193.8万港元,同比减少1.2%;每股盈利15.61港仙;拟派末期股息每股2.3港仙。公告称,公司拥有人应占纯利减少反映严峻市场环境及研发支出增加的合并影响,抵销了收益增长及销售费用减少所带来的裨益,导致纯利同比下滑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1191","BK1587","BK1583","00950","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622071591","title":"李氏大药厂(00950):茵若飒取得国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071591","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622071591?lang=zh_cn&edition=full","pubTime":"2026-03-25 21:37","pubTimestamp":1774445826,"startTime":"0","endTime":"0","summary":"智通财经APP讯,李氏大药厂(00950)发布公告,于2026年3月17日,中国国家药品监督管理局(国家药监局)已批准茵若飒(由Cosette Pharmaceuticals拥有并已授予李氏大药厂许可)用于治疗具有中重度症状(不包括泌尿系症状)的绝经后女性外阴阴道萎缩。继本公司全资附属公司兆科药业(合肥)有限公司进行的第III期、多中心、随机、双盲、平行对照临床试验成功完成后,是次获批标志着一个重要的里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1574","BK1587","00950","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145677103","title":"兆科眼科-B 2025年收入回落,持续推进多款眼科创新药布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1145677103","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145677103?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:50","pubTimestamp":1774439401,"startTime":"0","endTime":"0","summary":"兆科眼科-B于截至2025年12月31日的报告期内录得收入人民币31,974千元,较上一年度的人民币69,324千元出现下滑,主要由于部分药物及产品销售收益减少,以及一次性许可收入较上年度有所降低。毛利从2024年度的人民币51,797千元下降至人民币16,053千元。报告期末,兆科眼科-B的资产总值约为人民币1,935,312千元,负债总额约为人民币359,425千元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078438","title":"兆科眼科-B(06622)公布2025年业绩 税后亏损约2.09亿元 同比收窄12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078438","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622078438?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:46","pubTimestamp":1774439191,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B(06622)公布2025年业绩,收益3197.4万元,同比减少53.88%;税后亏损约2.09亿元,同比收窄12%。公告称,亏损减少主要源于集团继续严格控制行政费用及销售及分销开支,反映年内成本控制有所加强及营运架构效率提升。此外,研发开支随着若干主要开发里程碑达成而有所减少,并无如上一年度产生非经常性开支亦进一步推动改善。尽管并无如上一年度取得一次性的许可收入,且2025年利率下调令银行利息收入减少,惟集团取得的年内亏损仍然实质收窄。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1574","BK1587","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618106749","title":"兆科眼科-B(06622.HK)拟3月25日举行董事会会议批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2618106749","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618106749?lang=zh_cn&edition=full","pubTime":"2026-03-11 17:07","pubTimestamp":1773220027,"startTime":"0","endTime":"0","summary":"格隆汇3月11日丨兆科眼科-B(06622.HK)宣布,董事会会议将于2026年3月25日(星期三)举行,以(其中包括)考虑及批准本公司及其附属公司截至2025年12月31日止年度的年度业绩及其登载。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260311/32060518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","06622","BK1587","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618620480","title":"兆科眼科-B03月09日获主力加仓68.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618620480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618620480?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:15","pubTimestamp":1773044138,"startTime":"0","endTime":"0","summary":"03月09日, 兆科眼科-B股价涨0.59%,报收3.39元,成交金额570.2万元,换手率0.31%,振幅7.42%,量比2.30。兆科眼科-B今日主力资金净流入68.0万元,上一交易日主力净流入33.9万元。该股近5个交易日上涨5.28%,主力资金累计净流入102.1万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入198.8万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161802a6b1b570&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161802a6b1b570&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06622","BK1587","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616535094","title":"李氏大药厂03月04日主力净流出47.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616535094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616535094?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:15","pubTimestamp":1772612117,"startTime":"0","endTime":"0","summary":"03月04日, 李氏大药厂股价跌0.75%,报收1.32元,成交金额208.7万元,换手率0.27%,振幅5.26%,量比1.54。李氏大药厂今日主力资金净流出47.4万元,上一交易日主力净流出0万元。该股近5个交易日下跌8.28%,主力资金累计净流出92.1万元;近20日主力资金累计净流出103.6万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161557a44a5878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304161557a44a5878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1583","BK1574","BK1587","06622","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169829932","title":"兆科眼科(06622)公布2月股份变动月报表,股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1169829932","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169829932?lang=zh_cn&edition=full","pubTime":"2026-03-03 12:10","pubTimestamp":1772511057,"startTime":"0","endTime":"0","summary":"兆科眼科有限公司于2026年3月3日发布2026年2月股份变动月报表。公告显示,公司注册股本和已发行股本整体保持稳定,报告期内新增发行普通股779,000股,未发生股份回购或注销行为。截至2月底,公司已满足香港联交所相关规则要求的公众持股量。截至2月底,兆科眼科股本总数为548,749,012股普通股。公司在公告中确认,所有新增股份发行已获得董事会正式授权,并符合香港联交所《上市规则》和其他法律法规。该公告由董事李小羿签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616353093","title":"李氏大药厂03月02日主力净流出63.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616353093?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:15","pubTimestamp":1772439333,"startTime":"0","endTime":"0","summary":"03月02日, 李氏大药厂股价跌4.90%,报收1.36元,成交金额311.5万元,换手率0.38%,振幅5.59%,量比3.79。李氏大药厂今日主力资金净流出63.4万元,上一交易日主力净流入18.6万元。该股近5个交易日下跌9.33%,主力资金累计净流出61.8万元;近20日主力资金累计净流出57.7万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161747a4413949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302161747a4413949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1191","BK1574","06622","00950","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614898962","title":"李氏大药厂02月27日主力净流入18.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2614898962","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614898962?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:16","pubTimestamp":1772180170,"startTime":"0","endTime":"0","summary":"02月27日,李氏大药厂股价收平报1.43元,成交金额141.7万元,换手率0.17%,振幅3.50%,量比2.19。李氏大药厂今日主力资金净流入18.6万元,上一交易日主力净流出0万元。该股近5个交易日下跌2.72%,主力资金累计净流入1.6万元;近20日主力资金累计净流入32.9万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227162243a4cf0195&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227162243a4cf0195&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1583","06622","BK1587","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611192772","title":"李氏大药厂02月13日主力净流入23.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2611192772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611192772?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:15","pubTimestamp":1770970546,"startTime":"0","endTime":"0","summary":"02月13日, 李氏大药厂股价涨0.68%,报收1.47元,成交金额106.0万元,换手率0.12%,振幅3.42%,量比1.55。李氏大药厂今日主力资金净流入23.7万元,上一交易日主力净流出0万元。该股近5个交易日下跌1.34%,主力资金累计净流入23.7万元;近20日主力资金累计净流出17.2万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161928a6f6d3f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161928a6f6d3f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","00950","06622","BK1587","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609196514","title":"兆科眼科-B盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609196514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609196514?lang=zh_cn&edition=full","pubTime":"2026-02-06 13:39","pubTimestamp":1770356368,"startTime":"0","endTime":"0","summary":"2026年02月06日下午盘13时39分,兆科眼科-B股票出现异动,股价快速拉升5.11%。兆科眼科-B股票所在的药品行业中,整体跌幅为0.18%。其相关个股中,三爱健康集团、宝济药业-B、兆科眼科-B涨幅较大,振幅较大的相关个股有精优药业、联邦制药、兆科眼科-B,振幅分别为14.63%、9.34%、8.41%。兆科眼科-B公司简介:兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020613392897a52530&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020613392897a52530&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1191","BK1574","06622","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608518863","title":"李氏大药厂02月04日主力净流出18.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608518863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608518863?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192939,"startTime":"0","endTime":"0","summary":"02月04日, 李氏大药厂股价跌2.63%,报收1.48元,成交金额244.3万元,换手率0.28%,振幅4.61%,量比1.58。李氏大药厂今日主力资金净流出18.0万元,上一交易日主力净流出0万元。该股近5个交易日下跌8.64%,主力资金累计净流出36.0万元;近20日主力资金累计净流出47.6万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161851a47afbd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161851a47afbd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1574","BK1587","BK1583","00950","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609948399","title":"兆科眼科-B02月04日主力净流出25.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2609948399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609948399?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192934,"startTime":"0","endTime":"0","summary":"02月04日, 兆科眼科-B股价跌5.81%,报收3.24元,成交金额374.3万元,换手率0.21%,振幅6.69%,量比0.69。兆科眼科-B今日主力资金净流出25.5万元,上一交易日主力净流入59.8万元。该股近5个交易日下跌7.16%,主力资金累计净流入165.9万元;近20日主力资金累计净流入419.3万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161818a47afb31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161818a47afb31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","06622","BK1587","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608289538","title":"兆科眼科-B盘中异动 股价大跌5.16%报3.490港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608289538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608289538?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:35","pubTimestamp":1770017733,"startTime":"0","endTime":"0","summary":"2026年02月02日临近收盘15时35分,兆科眼科-B股票出现异动,股价急速下跌5.16%。截至发稿,该股报3.490港元/股,成交量92万股,换手率0.17%,振幅5.43%。资金方面,该股资金流入136.771万港元,流出170.779万港元。兆科眼科-B股票所在的药品行业中,整体跌幅为1.32%。其相关个股中,康哲药业、中智药业、励晶太平洋涨幅较大,振幅较大的相关个股有中智药业、康哲药业、石药集团,振幅分别为11.59%、10.48%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202153533953f67a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202153533953f67a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1587","06622","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607109629","title":"全球首个复方老花眼滴眼液获FDA批准上市,兆科眼科-B(6622.HK)抢占眼科创新赛道先机","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109629","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607109629?lang=zh_cn&edition=full","pubTime":"2026-01-30 14:48","pubTimestamp":1769755720,"startTime":"0","endTime":"0","summary":"兆科眼科宣布,其合作伙伴Tenpoint Therapeutics公司已获得美国FDA监管批准,允许老花眼治疗创新药物BRIMOCHOL™ PF上市销售。","market":"sh","thumbnail":"https://img7.gelonghui.com/column/5.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/5.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3725172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["06622","BK1191","BK1574","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607082586","title":"兆科眼科-B(06622):Tenpoint接获FDA在美国就BRIMOCHOL™ PF发出的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2607082586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607082586?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:36","pubTimestamp":1769690182,"startTime":"0","endTime":"0","summary":"此滴眼液于临床试验期间名为BRIMOCHOL PF,在美国的商用名称将为YUVEZZI,作为用于治疗老花眼的创新药物。此批准在Tenpoint成功完成第3期临床试验后取得。此外,在BRIO II研究监测的逾72000个治疗日中,BRIMOCHOL PF耐受性良好,未观察到治疗相关的严重不良事件。在BRIO II研究中,接受BRIMOCHOL PF的受试者出现眼部充血不良事件的报告率低于单独接受卡巴胆硷的受试者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"兆科眼科-B(06622):Tenpoint接获FDA在美国就BRIMOCHOL™ PF发出的批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1587","BK1574","BK1583","06622"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2607709270","title":"港股兆科眼科-B(06622.HK)盘中涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607709270","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607709270?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:03","pubTimestamp":1769673781,"startTime":"0","endTime":"0","summary":"每经AI快讯,兆科眼科-B(06622.HK)盘中涨超7%,截至发稿,涨3.44%,报3.61港元,成交额1143.15万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601293635223587.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601293635223587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1574","BK1587","BK1191","VT","BK4588","BK4585","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607709838","title":"港股异动 | 兆科眼科-B(06622)盘中涨超7% 公司扩大与AFT的合作至新加坡 与千寿达成越南合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2607709838","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607709838?lang=zh_cn&edition=full","pubTime":"2026-01-29 15:56","pubTimestamp":1769673400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,兆科眼科-B盘中涨超7%,截至发稿,涨3.44%,报3.61港元,成交额1143.15万港元。消息面上,1月26日,兆科眼科宣布,将其核心老花眼治疗药物BRIMOCHOL PF在新加坡和越南的独家商业化权利,分别授予新西兰的AFT Pharmaceuticals和日本的千寿制药。至此,兆科眼科其全球化商业版图已延伸至韩国、澳洲、新西兰、泰国、印度尼西亚、台湾地区、新加坡和越南八个市场。根据协议,兆科眼科授予AFT在新加坡、授予千寿在越南的独家分销权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","VT","BK1574","BK1587","BK4588","AFT","BK1583","BK4585","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":-0.0528},{"period":"3month","weight":-0.1408},{"period":"6month","weight":-0.0161},{"period":"1year","weight":0.9805},{"period":"ytd","weight":0.0304}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.0044},{"period":"3month","weight":-0.0363},{"period":"6month","weight":0.0277},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0124}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兆科眼科有限公司是一家主要从事眼科药物及产品的开发、生产及营销的投资控股公司。该公司的主要产品包括用于治疗近视的NVK002(阿托品)、用于治疗干眼症的环孢素A眼凝胶以及用于治疗wAMD的TAB014(贝伐单抗)。该公司产品主要用于干眼症(DED)、近视、老花眼、湿性老年黄斑部病变(wAMD)和糖尿病黄斑水肿(DME)、青光眼及角膜上皮细胞功能障碍(CED)等影响眼前节及眼后节的眼科疾病的治疗。该公司在中国国内及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.147188},{"month":2,"riseRate":0.2,"avgChangeRate":-0.134185},{"month":3,"riseRate":0.2,"avgChangeRate":-0.040318},{"month":4,"riseRate":0.4,"avgChangeRate":0.029614},{"month":5,"riseRate":0.4,"avgChangeRate":0.043975},{"month":6,"riseRate":0.2,"avgChangeRate":0.042663},{"month":7,"riseRate":0.4,"avgChangeRate":-0.054975},{"month":8,"riseRate":0.2,"avgChangeRate":-0.017626},{"month":9,"riseRate":0.6,"avgChangeRate":0.007418},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082811},{"month":11,"riseRate":0.4,"avgChangeRate":0.029799},{"month":12,"riseRate":0.2,"avgChangeRate":-0.018114}],"exchange":"SEHK","name":"兆科眼科-B","nameEN":"ZHAOKE OPHTH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兆科眼科-B,06622,兆科眼科-B股票,兆科眼科-B股票老虎,兆科眼科-B股票老虎国际,兆科眼科-B行情,兆科眼科-B股票行情,兆科眼科-B股价,兆科眼科-B股市,兆科眼科-B股票价格,兆科眼科-B股票交易,兆科眼科-B股票购买,兆科眼科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兆科眼科-B(06622)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兆科眼科-B(06622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}